Sponsored By:

Draw Down Your Dosage of Mylan

MYL could well be hit with profit taking in the weeks ahead

   

Mylan (MYL) – On May 29, with Mylan at under $32, I suggested MYL as a trade with a target of $36, saying:

“In mid-May the stock broke through a double top to new all-time highs on high volume and a CBR buy signal, and the MACD is bullish. The trading target for MYL is $36, but long-term investors will probably enjoy a higher return.”

Despite a recent upgrade by UBS in which it raised its 12-month target on Mylan to $39 from $36, current market conditions suggest that traders should take profits in stocks that have attained short-term goals. Since it is likely that MYL could retreat through the recent continuation gap, sell now, but buy again on a retracement under $34.

MYLprofits 300x187 Draw Down Your Dosage of Mylan
Click to Enlarge

chart key Draw Down Your Dosage of Mylan


Article printed from InvestorPlace Media, http://investorplace.com/2013/08/draw-down-your-dosage-of-mylan-myl/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.